Sanofi
Annual return '25
+103.6%
SPY '25
+17.7%
Alpha
+85.8ptsvs SPY
Invested
$336M
Holdings
9
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 98%. 3 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$MGTX
MeiraGTx Holdings plc
Held since at least Q1 2024
31.4%
02
$INBX
Inhibrx Biosciences, Inc.
Held since at least Q1 2024
23.2%
03
$NVAX
Novavax
Held since at least Q1 2024
16.7%
04
$ANAB
AnaptysBio
Held since at least Q1 2024
9.0%
05
$AGMB
Agomab Therapeutics NV
Held since at least Q1 2024
8.7%
06
$MPLT
MapLight Therapeutics Inc.
Held since at least Q1 2024
5.5%
07
$IMRX
Immuneering Corp
Held since at least Q1 2024
4.2%
08
$ELDN
Eledon
Held since at least Q1 2024
0.7%
09
$QTTB
Q32 Bio Inc.
Held since at least Q1 2024
0.5%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 11:12 UTC.